Regeneron Pharmaceuticals, Inc.

REGN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$2,488$2,730$3,106$2,886
Short-Term Investments$6,524$8,115$4,636$2,809
Receivables$6,212$5,667$5,329$6,037
Inventory$3,087$2,581$2,402$1,951
Other Curr. Assets$349$387$411$332
Total Curr. Assets$18,661$19,479$15,884$14,015
Property Plant & Equip (Net)$4,600$4,146$3,763$3,482
Goodwill$0$0$0$0
Intangibles$1,149$1,039$916$7
Long-Term Investments$8,900$5,397$6,592$6,838
Tax Assets$3,314$2,575$1,724$877
Other NC Assets$1,136$444$336$216
Total NC Assets$19,099$13,601$13,330$11,420
Other Assets$0$0$0$0
Total Assets$37,759$33,080$29,215$25,435
Liabilities
Payables$790$607$589$564
Short-Term Debt$0$0$0$720
Tax Payable$213$0$0$326
Deferred Revenue$628$459$478$442
Other Curr. Liab.$2,314$2,358$2,074$1,881
Total Curr. Liab.$3,944$3,423$3,141$3,933
LT Debt$2,704$2,703$2,701$1,980
Deferred Rev, NC$186$127$70$73
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,571$854$638$680
Total NC Liab.$4,462$3,684$3,409$2,734
Other Liabilities$0$0$0$0
Cap. Leases$720$720$720$720
Total Liabilities$8,406$7,107$6,551$6,666
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings$31,673$27,260$23,307$18,968
AOCI-$8-$81-$239-$26
Other Equity-$2,312-$1,206-$404-$173
Total Equity$29,354$25,973$22,664$18,769
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$37,759$33,080$29,215$25,435
Net Debt$216-$27-$405-$186